Article information
Abstract
There is a strong association between cardiovascular diseases, thromboembolism, and atherosclerosis with endothelial dysfunction. The relationship of the latter with neuropsychiatric diseases such as the post traumatic stress disorder (PTSD) stands as a risk factor for the development of atherosclerotic phenomena.
ObjectiveTo disclose a meaningful association between PTSD and higher values of endothelial dysfunction molecules like e-Selectin, s-ICAM-1 and v-CAM-1, in comparison with healthy subjects without PTSD.
Methods24 patients with PTSD and 24 healthy subjects were selected e-Selectin, v-CAM-1 e soluble ICAM-1 levels were measured in plasma. The PTSD severity symptoms scale and the Trauma Symptom Checklist were administered to both samples.
ResultsA meaningful and robust correlation between endothelial dysfunction markers e-Selectin, s-ICAM-1 y v-CAM-1 plasma levels and the severity of the PTSD was disclosed.
ConclusionThere is a continual relationship between PTSD symptoms severity and plasmatic levels of endothelial dysfunction markers. This relationship can explain the probability of developing cardiovascular diseases and atherogenesis and traumatic life events which ends up as PTSD at common grounds with inflammatory vascular response.
Keywords:
Post traumatic stress disorder
Endothelial dysfunction
E-Selectin
V-CAM-1
S-ICAM-1
Resumen
La asociación de enfermedades cardiovasculares, tromboembolismo y aterosclerosis se asocia significativamente con disfunción endotelial. La posibilidad de asociación de esta última con enfermedades psiquiátricas como el trastorno por estrés postraumático (TEPT) constituiría un factor de riesgo para el desarrollo de fenómenos de aterosclerosis.
ObjetivoDetectar una asociación significativa entre el TEPT y mayores valores de moléculas de disfunción endotelial como e-Selectina, s-ICAM-1 y v-CAM-1, en comparación con sujetos sanos sin TEPT.
MétodosSe seleccionaron 24 pacientes con TEPT y 24 sujetos sanos control sin TEPT y se midieron e-Selectina, v-CAM-1 e ICAM-1 soluble en plasma en ambos grupos. Además se les administró la escala de gravedad de síntomas del trastorno por estrés postraumático y el Trauma Symptom Checklist para evaluación del TEPT.
ResultadosSe comprobó una asociación significativa y robusta entre e-Selectina, s-ICAM-1 y v-CAM-1 y la gravedad del TEPT.
ConclusionesHay una relación continua entre la severidad de los síntomas de TEPT y los niveles plasmáticos de marcadores de disfunción endotelial. Este vínculo puede explicar la asociación entre la probabilidad de desarrollar enfermedades cardiovasculares y aterogénesis y los eventos traumáticos conducentes a desarrollar TEPT en el nivel de la respuesta vascular inflamatoria común.
Palabras clave:
Trastorno de estrés postraumático
Disfunción endotelial
E-Selectina
V-CAM-1
S-ICAM-1
Full text is only aviable in PDF
References
[1.]
R.C. Kessler, A. Sonnega, E. Bromet, M. Hughes, C.B. Nelson.
Posttraumatic stress disorder in the National Comorbidity Survey.
Arch Gen Psychiatry, 52 (1995), pp. 1048-1060
[2.]
H. Spindler, S.S. Pedersen.
Posttraumatic stress disorder in the wake of heart disease: prevalence, risk factors, and future research directions.
Psychosom Med, 67 (2005), pp. 715-723
[3.]
R. Von Känel, U. Hepp, C. Buddeberg, M. Keel, L. Mica, K. Aschbacher, et al.
Altered Blood Coagulation in Patients With Posttraumatic Stress Disorder.
Psychosom Med, 68 (2006), pp. 598-604
[4.]
S.B. Updesh, A. Rohit.
Cardiovascular manifestations of posttraumatic stress disorder.
J Natl Med Assoc, 99 (2007), pp. 642-649
[5.]
L.D. Kubzansky, K.C. Koenen, C. Jones, W.W. Eaton.
A prospective study of posttraumatic stress disorder symptoms and coronary heart disease in women.
Health Psychol, 28 (2009), pp. 125-130
[6.]
E. Guler, J.P. Schmid, L. Wiedemar, H. Saner, U. Schnyder, R. Von Känel.
Clinical Diagnosis of Posttraumatic Stress Disorder After Myocardial Infarction.
Clin Cardiol, 32 (2009), pp. 125-129
[7.]
L.P. Rocha, J.C. Peterson, B. Meyers, C. Boutin-Foster, M.E. Charlson, N. Jayasinghe, et al.
Incidence of Posttraumatic Stress Disorder (PTSD) after Myocardial Infarction (MI) and Predictors of PTSD Symptoms Post-MI.
A Brief Report The International Journal of Psychiatry in Medicine, 38 (2008), pp. 297-306
[8.]
L.D Kubzansky.
Is PTSD related to development of heart disease? An update.
Cleve Clin J Med, 76 (2009), pp. s60-s65
[9.]
C.E. Romero.
Depresión y enfermedad cardiovascular.
Rev Urug Cardiol, 22 (2007), pp. 92-109
[10.]
R. Von Känel, U. Hepp, R. Traber, B. Kraemer, L. Mica, M. Keel, et al.
Measures of endothelial dysfunction in plasma of patients with posttraumatic stress disorder.
Psychiatry Res, 158 (2008), pp. 363-373
[11.]
F. Vivanco, J.L. Martín-Ventura, M.C. Durán, M.G. Barderas, L. Blanco- Colio, V.M. Dardé, et al.
Quest for novel cardiovascular biomarkers by proteomic analysis.
J Proteome Res, 4 (2005), pp. 1181-1191
[12.]
P.M. Ridker, C.H. Hennekens, B. Roitman-Johnson, M.J. Stampfer, J. Allen.
Plasma concentration of soluble intercellular adhesion molecule 1 and risks of future myocardial infarction in apparently healthy men.
Lancet, 351 (1998), pp. 88-92
[13.]
P.M. Ridker, C.H. Hennekens, J.E. Buring, N. Rifai.
C-reactive protein and other markers of inflammation in the prediction of cardiovascular disease in women.
N Engl J Med, 342 (2000), pp. 836-843
[14.]
S.J. Hwang, C.M. Ballantyne, A.R. Sharrett, L.C. Smith, C.E. Davis, A.M. Gotto, et al.
Circulating adhesion molecules V-CAM-1 ICAM-1, and E-selectin in carotid atherosclerosis and incident coronary heart disease cases: the Atherosclerosis Risk In Communities (ARIC) study.
Circulation, 96 (1997), pp. 4219-4225
[15.]
von Känel R, Hepp U, Traber R, Kraemer B, Mica L, Keel M, et al. Measures of endothelial dysfunction in plasma of patients with posttraumatic stress disorder Psychiatry Research, 158;363-73.
[16.]
P.M. Ridker, J.E. Buring, N. Rifai.
Soluble P-selectin and the risk of future cardiovascular events.
Circulation, 103 (2001), pp. 491-495
[17.]
S. Blankenberg, H.J. Rupprecht, C. Bickel, D. Peetz, G. Hafner, L. Tiret, et al.
Circulating cell adhesion molecules and death in patients with coronary artery disease.
Circulation, 104 (2001), pp. 1336-1342
[18.]
N.T. Mulvihill, J.B. Foley, R.T. Murphy, R. Curtin, P.A. Crean, M. Walsh.
Risk stratification in unstable angina and non-Q wave myocardial infarction using soluble cell adhesion molecules.
Heart, 85 (2001), pp. 623-627
[19.]
I. Malik, J. Danesh, P. Whincup, V. Bhatia, O. Papacosta, M. Walker, et al.
Soluble adhesion molecules and prediction of coronary heart disease: a prospective study and meta-analysis.
Lancet, 358 (2001), pp. 971-976
[20.]
J. Constans, C. Conri.
Circulating markers of endotelial function in cardiovascular disease.
Clin Chem Acta, 368 (2006), pp. 33-47
[21.]
P.M. Ridker, N.J. Brown, D.E. Vaughan, D.G. Harrison, J.L. Metha.
Established and emerging plasma biomarkers in the prediction of first atherothrombotic events.
Circulation, 109 (2004), pp. 6-19
[22.]
P.E. Szimitko, C.H. Wang, R.D. Weisel, J.R. De Almeida, T.J. Anderson, S. Verma.
New markers of inflammation and endothelial cell activation Part I.
Circulation, 108 (2003), pp. 1917-1923
[23.]
N. Mulvihill, B. Foley, P. Crean, M. Walsh.
Prediction of cardiovascular risk using soluble cell adhesion molecules.
Eur Heart J, 23 (2002), pp. 1569-1574
[24.]
P.M. Ridker, C.H. Hennekens, B. Roitman-Johnson, M.J. Stampfer, J. Allen.
Plasma concentration of soluble intercellular adhesion molecule 1 and risks of future myocardial infarction in apparently healthy men.
Lancet, 351 (1998), pp. 88-92
[25.]
J.L. Martín, L.M. Blanco, J. Tuñón, B. Muñoz, J. Madrigal, J.A. Moreno, et al.
Biomarcadores en la medicina cardiovascular.
Rev Esp Cardiol, 62 (2009), pp. 677-688
[26.]
C. Duboscq.
Rol de la heterogeneidad endotelial en la regulación de la Hemostasia.
Acta bioquím clín latinoam, 40 (2006), pp. 317-325
[27.]
A. Galán, X. Formiguera, C. Rey-Joly.
Dimetilarginina asimétrica como marcador de riesgo cardiovascular.
Med Clin (Barc), 131 (2008), pp. 271-275
[28.]
T. Münzel, C. Sinning, F. Post, A. Warnholtz, E. Schulz.
Pathophysiology, diagnosis and prognostic implications of endothelial dysfunction.
Ann Med, 40 (2008), pp. 180-196
[29.]
R. Von Känel, B. Kraemer, H. Saner, J.P. Schid, C.C. Abbas, S. Begré.
Posttraumatic stress disorder and dyslipidemia: previous research and novel findings from patients with PTSD caused by myocardial infarction.
World J Biol Psychiatry, 11 (2010), pp. 141-147
[30.]
G.D. Lowe, J.W. Yarnell, A. Rumley, D. Bainton, P.M. Sweetnam.
C-Reactive protein, fibrin D-dimer, and incident ischemic heart disease in the speedwell study-Are inflammation and fibrin turnover linked in pathogenesis?.
Arterioscler Thromb Vasc Biol, 21 (2005), pp. 603-610
[31.]
I. Malik, J. Danesh, P. Whincup, V. Bhatia, O. Papacosta, M. Walker, et al.
Soluble adhesion molecules and prediction of coronary heart disease: a prospective study and meta-analysis.
Lancet, 358 (2001), pp. 971-976
[32.]
T.A. Springer.
Traffic signals for lymphocyte recirculation and leukocyte emigration: The multistep paradigm.
Cell, 76 (1994), pp. 301-314
[33.]
L. Yang, R.M. Froio, T.E. Sciuto, A.M. Dvorak, R. Alon, F.W. Luscinskas.
ICAM-1 regulates neutrophil adhesion and transcellular migration of TNF-alpha-activated vascular endothelium under flow.
Blood, 106 (2005), pp. 584-592
[34.]
K. Brown, L. Cherry, G.D. Lowe, A. Rumley, N. Sattar, J. Tchernova, et al.
Associations of adiponectin with metabolic and vascular risk parameters in the British Regional Heart Study reveal stronger links to insulin resistance-related than to coronory heart disease risk-related parameters.
Int J Obes, 31 (2007), pp. 1089-1098
[35.]
T. Carrizo, M. Prado, M.S. Velarde, E.I. Díaz, M.C. Bazán, A.V. Abregú.
e-Selectina soluble en una población infanto-juvenil con diabetes tipo 1.
Medicina (Buenos Aires), 68 (2008), pp. 193-197
[36.]
M.J. Davies, J.L. Gordon, A.J.H. Gearing, R. Pigott, N. Woolf, D. Katz, et al.
The expression of the adhesion molecules ICAM-1, V-CAM-1, PECAM and E-selectin in human artherosclerosis.
J Pathol, 171 (1993), pp. 223-229
[37.]
A. Ceriello, L. Quagliaro, L. Piconi, R. Assaloni, R. Da Ros, A. Maier, et al.
Effect of postprandial hypertriglyceridemia and hyperglycemia on circulating adhesion molecules and oxidative stress generation and the possible role of simvastatin treatment.
Diabetes, 23 (2004), pp. 701-710
[38.]
O. Barreiro, M. Yañez, J.M. Serrador, M.C. Montoya, M. Vicente- Manzanares, R. Tejedor, et al.
Dynamic interaction of V-CAM-1 and ICAM-1 with moesin and ezrin in a novel endothelial docking structure for adherent leukocytes.
J Cell Biol, 157 (2002), pp. 1233-1245
[39.]
L. Yang, R.M. Froio, T.E. Sciuto, A.M. Dvorak, R. Alon, F.W. Luscinskas.
ICAM-1 regulates neutrophil adhesion and transcellular migration of TNF-alpha-activated vascular endothelium under flow.
Blood, 106 (2005), pp. 584-592
[40.]
M. Lopes-Virella, R. Carter, G. Gillbert, R. Klein, M. Jaffa, A. Jenkins, et al.
Risk Factors Related to Inflammation and Endothelial Dysfunction in the DCCT/EDIC Cohort and Their Relationship With Nephropathy and Macrovascular Complications.
Diabetes Care, 31 (2008), pp. 2006-2012
[41.]
E. Echeburúa, P. Corral, P.J. Amor, I. Zubizarreta, B. Sarasúa.
Escala de gravedad de Síntomas del Trastorno por estrés Postraumático Propiedades psicométricas.
Análisis y Modificación de Conducta, 23 (1997), pp. 503-526
[42.]
J. Briere, M. Runtz.
The trauma symptom checklist (TSC-33): early data on a new scale.
J Interpers Violence, 4 (1989), pp. 151-163
[43.]
D Machin, M.J. Campbell, P. Fayers, A. Pinol.
Statistical Tables for the Design of Clinical Studies.
2nd edn., Blackwell, (1998),
[44.]
C. Pizzi, S. Mancinin, L. Angeloni, F. Fontana, L. Manzoli, G.M. Costa.
Effects of Selective Serotonin Reuptake Inhibitor Therapy on Endothelial Function and Inflammatory Markers in Patients With Coronary Heart Disease.
Clin Pharmacol Ther, 86 (2009), pp. 527-532
[45.]
D.V. Sheehan, Y. Lecrubier, K.H. Sheehan, P. Amorim, J. Janavs, E. Weiller, et al.
The Mini-International Neuropsychiatric Interview (M.I.N.I.): the development and validation of a structured diagnostic psychiatric interview for DSM-IV and ICD-10.
J Clin Psychiatry, 59 (1998), pp. 22-33
[46.]
M.L. Gander, R. Von Känel.
Myocardial infarction and posttraumatic stress disorder: frequency, outcome and atherosclerotic mechanisms.
Eur J Cardiovasc Prev Rehabil, 13 (2006), pp. 165-172
[47.]
R. Ho, L.F. Neo, A. Chua, A. Cheak, A. Mak.
Research on Psychoneuroimmunology: Does Stress Influence Immunity and Cause Coronary Artery Disease?.
Ann Acad Med Singapore, 39 (2010), pp. 191-196
[48.]
A. Hänsel, R. Von Känel.
The ventro-medial prefrontal cortex: a major link between the autonomic nervous system, regulation of emotion, and stress reactivity?.
Biopsychosoc Med, 5 (2008), pp. 2-21
[49.]
R. Yehuda.
Status of Glucocorticoid Alterations in Post-traumatic Stress Disorder.
Ann N Y Acad Sci, 1179 (2009), pp. 56-69
[50.]
M.L. Meewisse, J.B. Reitsma, G. De Vries, B.P.R. Gersons, M. Olff.
Cortisol and post-traumatic stress disorder in adults: Systematic review and meta-analysis.
Br J Psychiatry, 191 (2007), pp. 387-392
[51.]
A. Steptoe, M. Hamer, Y. Chida.
The effects of acute psychological stress on circulating inflammatory factors in humans: A review and meta-analysis.
Brain Behav Immun, 21 (2007), pp. 901-912
[52.]
A. Steptoe, N. Owen, S. Kunz-Ebrecht, V. Mohamed-Ali.
Inflammatory cytokines, socioeconomic status, and acute stress responsivity.
Brain Behavior and Immunity, 16 (2002), pp. 774-784
[53.]
T.A. Elhadd, T.A. Abdu, J. Oxtoby, G. Kennedy, M. McLaren, R. Neary, et al.
Biochemical and Biophysical Markers of Endothelial Dysfunction in Adults with Hypopituitarism and Severe GH Deficiency.
J Clin Endocrinol Metab, 86 (2001), pp. 4223-4232
[54.]
P. Pervanidou, G. Kolaitis, S. Charitaki, A. Margeli, S. Ferentinos, C. Bakoula, et al.
Elevated morning serum interleukin (IL)-6 or evening salivary cortisol concentrations predict posttraumatic stress disorder in children and adolescents six months after a motor vehicle accident.
Psychoneuroendocrinology, 32 (2007), pp. 991-999
[55.]
K. Pitzalis, N. Pipitone, M. Perretti.
Regulation of Leukocyte- Endothelial Interactions by Glucocorticoids.
Ann N Y Acad Sci, 966 (2002), pp. 108-118
[56.]
Q. Cheng, S.J. McKeown, L. Santos, F.S. Santiago, L.M. Khachigian, E.F. Morand, et al.
Macrophage Migration Inhibitory Factor Increases Leukocyte-Endothelial Interactions in Human Endothelial Cells via Promotion of Expression of Adhesion Molecules.
J Immunol, 185 (2010), pp. 1238-1247
[57.]
E. Charmandari, C. Tsigos, G.P. Chrousos.
Neuroendocrinology of stress.
Ann Rev Physiol, 67 (2005), pp. 259-284
[58.]
F. Zhang, W. Yu, J.L. Hargrove, P. Greenspan, R.G. Dean, E.W. Taylor, et al.
Inhibition of TNF-a induced ICAM-1, V-CAM-1 and E-selectin expression by selenium.
Atherosclerosis, 161 (2002), pp. 381-386
[59.]
I.J. Lenkov, G.P. Chrousos.
Stress hormones TH1/TH2-patterns, pro/anti- inflammatory cytokines and susceptibility to disease.
Trends Endocrinol Metab, 10 (1999), pp. 359-368
[60.]
C. Schmidt, J. Hulthe, B. Fagerberg.
Baseline ICAM-1 and V-CAM-1 are Increased in Initially Healthy Middle-Aged Men Who Develop Cardiovascular Disease During 6.6 Years of Follow-Up.
Angiology, 60 (2009), pp. 108-114
[61.]
A. Rohatgi, A.W. Owens, A. Khera, C.R. Ayers, K. Banks, S.R. Das, et al.
Differential Associations Between Soluble Cellular Adhesion Molecules and Atherosclerosis in the Dallas Heart Study. A Distinct Role for Soluble Endothelial Cell-Selective Adhesion Molecule.
Arterioscler Thromb Vasc Biol, 29 (2009), pp. 1684-1690
[62.]
B.S. McEwen.
Central effects of stress hormones in health and disease: Understanding the protective and damaging effects of stress and stress mediators.
Eur J Pharmacol, 583 (2008), pp. 174-185
[63.]
A.M. Müller, C. Cronen, L.I. Kupferwasser, H. Oelert, K. Müller, C. James Kirkpatrick.
Expression of endothelial cell adhesion molecules on heart valves: up-regulation in degeneration as well as acute endocarditis.
J Pathol, 191 (2000), pp. 54-60
[64.]
E.M. Friedman, D.R. Williams, B.H. Singer, C.D. Ryff.
Chronic discrimination predicts higher circulating levels of E-selectin in a national sample: The MIDUS study.
Brain Behavior and Immunity, 23 (2009), pp. 684-692
[65.]
J.A. Boscarino.
Psychobiologic predictors of disease mortality after psychological trauma: Implications for research and clinical surveillance.
J Nerv Ment Dis, 196 (2008), pp. 100-107
[66.]
E.A. Dedert, P.S. Calhoun, L.L. Watkins, A. Sherwood, J.C. Beckham.
Posttraumatic Stress Disorder, Cardiovascular, and Metabolic Disease: A Review of the Evidence.
Ann Behav Med, 39 (2010), pp. 61-78
[67.]
D. Craiem, G. Chironi, A. Simon, J. Levenson.
New assessment of endothelium-dependent flow-mediated vasodilation to characterize endothelium dysfunction.
Am J Ther, 15 (2008), pp. 340-344
Copyright © 2010. SEP y SEPB